SCHEMBL8910040

SCHEMBL8910040

O=[C]C1c2ccccc2C=Cc2ccccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.45
CYP2D6 P10635 3/20 0.38
KDM4E B2RXH2 5/20 0.36
HSD17B10 Q99714 3/20 0.36
TP53 P04637 2/20 0.36
CYP3A4 P08684 2/20 0.36
LMNA P02545 2/20 0.36
BRD4 O60885 1/20 0.36
CCL2 P13500 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM1 P11229 1/20 0.36
DRD2 P14416 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
NFKB1 P19838 1/20 0.36
CHRM3 P20309 1/20 0.36
SLC6A2 P23975 1/20 0.36
HTR2C P28335 1/20 0.36
ADRA1A P35348 1/20 0.36
HRH1 P35367 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3983556 0.87 CYP2D6 (0.41) HTR2ACYP2D6KDM4EHSD17B10TP53
SCHEMBL2198383 0.86 HTR2A (0.38) HTR2ACYP2D6KDM4EHSD17B10TP53
SCHEMBL3550306 0.76 HTR2A (0.45) HTR2ACYP2D6KDM4EHSD17B10TP53
SCHEMBL68229 0.75 GPR3 (0.41) HTR2ACYP2D6MEN1KMT2AALDH1A1
SCHEMBL194746 0.73 HTR2A (0.38) HTR2ACYP2D6KDM4EHSD17B10TP53
SCHEMBL7913606 0.73 PIM1 (0.44) HTR2ACYP2D6KDM4EHSD17B10TP53
SCHEMBL10080430 0.72 HTR2A (0.56) HTR2ACYP2D6KDM4EHSD17B10TP53
Hydrochloric Acid SCHEMBL9691406 0.70 HTR2A (0.54) HTR2ACYP2D6KDM4EHSD17B10TP53
SCHEMBL9187132 0.70 ACP3 (0.48) HTR2ARETIDO1CES1
SCHEMBL68804 0.70 MAOA (0.52) TP53LMNAMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5622953-A DRUG RESISTANT TO ANTICANCER CHEMOTHERAPEUTIC DRUG BASF AKTIENGESELLSCHAFT (DE) 1997-04-22 US disclosed
EP-0691962-A1 1-AMINO-3-PHENOXY PROPANE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE BASF AKTIENGESELLSCHAFT (DE) 1996-01-17 EP disclosed
US-5405843-A Anticancer drug potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1995-04-11 US disclosed
EP-0363212-B1 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS (JP) 1995-01-04 EP disclosed
WO-1994022842-A1 1-AMINO-3-PHENOXY PROPANE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE BASF AKTIENGESELLSCHAFT (DE) 1994-10-13 WO disclosed
US-5204348-A Quinoline derivatives MITSUI TOATSU CHEMICALS INC. (JP) 1993-04-20 US disclosed
US-5112817-A Anticancer Drug Potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1992-05-12 US disclosed
EP-0363212-A2 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS, Inc. (JP) 1990-04-11 EP disclosed